Isomorphic Labs Raises $5B Series C, Biotech’s Biggest Private Round, to Push AI-Designed Drugs Toward Clinical Trials
AI-generated summary Isomorphic Labs announced on Tuesday, 17 November 2026, that it has raised $5 billion in a Series C round to scale its proprietary drug design engine called IsoDDE. BioSpace reports that the funding round is the largest private fundraise in the history of the biotech industry.